NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
Back to search
Official data from USPTO
C CELLPOINT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
09/10/2024
Trademark type
Combined
Nice classes
5, 41, 42, 44
Filing date
02/08/2023
Registration date
09/10/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
09/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Mechelen, BE
Examiner
BERLIN, JUSTIN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a red dot to the left of the letter "C" outlined in a blue and green background, to the left of the word "CELLPOINT" in stylized blue font.
Holders and representatives
Holders
Galapagos NV
Representatives
Alexandra MacKay STITES & HARBISON PLLC
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical substances and preparations for human usepharmaceutical preparations and engineered patient T cells for the treatment of cancer; biopharmaceutical substances and preparations for human usebiopharmaceutical preparations and engineered patient T cells for the treatment of cancer; clinical diagnostic reagents for medical use
Class 41
Education servicesorganizing and conducting conferencesseminarsworkshops and classes in the fields of chemistrymedicinal chemistrybiochemistrybiotechnologydrug discoverydrug development and pharmaceuticals; provision of trainingprovision of training in the fields of chemistrymedicinal chemistrybiochemistrybiotechnologydrug discoverydrug development and pharmaceuticals
Class 42
Medicalscientific and industrial research services in the field of pharmaceuticalsengineered patient T-cellscell therapygene therapy; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expressionanalysis and testing of cells to determine the presence of particular genes; analysis and testing of cells to determine efficacy for treatment of cancer; developmentexaminationquality controltesting of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; developmentlaboratory analysis and testing of medicaments; development of test systems in the nature of testing procedures and protocolscomputer software for testingreagents and testing kits for testing for pharmaceutical and biopharmaceutical products; development of databases in the medicalpharmaceutical and biopharmaceutical field and development of computer databanks containing information concerning gene expression and gene therapy; pharmaceutical drug development services; scientific research in the nature of conducting clinical trials for others; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 44
Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others being engineered patient T-cells; medical servicesStemcell and celltherapy services; Medical services relating to the removaltreatment and processing of human cells
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/25/2024
PUBO
PUBLISHED FOR OPPOSITION
06/25/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/16/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2024
ALIE
ASSIGNED TO LIE
02/07/2024
DOCK
ASSIGNED TO EXAMINER
11/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/25/2023
GNRT
NON-FINAL ACTION E-MAILED
08/25/2023
CNRT
NON-FINAL ACTION WRITTEN
08/25/2023
DOCK
ASSIGNED TO EXAMINER
08/21/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2023
NWAP
NEW APPLICATION ENTERED
02/11/2023
Continuous trademark protection
Get notified about every new filing that threatens C CELLPOINT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.